Skip to content

Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy

Long-term Observation of Symptomatic Women With Uterine Fibroids Who Have Been Treated With Ulipristal Acetate: Findings on Symptomatology, Morphological Structure, Endometrial Patterns

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03972917
Enrollment
89
Registered
2019-06-04
Start date
2018-11-01
Completion date
2021-09-21
Last updated
2023-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea, Endometrium Hyperplasia, Myoma, Uterine Bleeding, Dysfunctional, Uterine Bleeding Heavy

Keywords

ulipristal acetate, myoma, leiomyoma, endometrial patterns, symptomatology

Brief summary

A prospective observational study on italian women undergoing ulipristal acetate (uPa) therapy for symptomatic myomas and its impact on symptomatology and moreover on myomas architecture. We also evaluate changes in the endometrial pattern of selected women.

Interventions

DIAGNOSTIC_TESTTransvaginal ultrasonographic examination

Evaluation of endometrial thickness; myoma size and volume

Sponsors

University of Campania Luigi Vanvitelli
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* number of myomas from 1 to 4 * heavy menstrual bleeding * conservative treatment request

Exclusion criteria

* concurrent endometrial pathology * post-menopausal status * hepatic pathology * endocrine or metabolic disorders

Design outcomes

Primary

MeasureTime frame
Dysmenhorrea (VAS score)12 months
Endometrial thickess (mm)12 months
Myoma's diameter (mm)12 months

Secondary

MeasureTime frameDescription
Live birth rate (LBR)12 monthsLive birth rate if women conceived spontaneously or through ARTs after treatment

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026